The Conversation (0)
Chart
Detailed Quote
Biosyent Inc is a growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn and Tibella.
Featured Articles and Interviews
Apr 21, 2026
5 Best-performing Canadian Pharma Stocks in 2026
May 08, 2024
Canadian Pharma Stocks: 5 Biggest Companies
Press Releases
Jun 15, 2026
BioSyent to Present at Planet MicroCap Las Vegas
May 14, 2026
BioSyent Declares Second Quarter 2026 Dividend
See More Press Releases
Alert Options
No alert set
INN Article Notification
Alert Option
You will be notified when this event occurs. No additional settings needed.



